GlobalData Plc
  • Obesity treatment shifting from gastric bands to balloons in $1.9 billion bariatric surgery market by 2023

The market for bariatric surgery devices, which encompasses 39 countries and includes bariatric stapling devices, gastric bands, and gastric balloons, will rise from around $1.1 billion in 2016 to $1.9 billion by 2023, representing a compound annual growth rate of 7.1%, according to research and consulting firm GlobalData.

The company’s latest report states that the key drivers of this relatively strong growth will include the rising prevalence of obesity, continued advancement in bariatric procedures, and the drive towards minimally invasive and non-invasive procedures.

Brigitte Babin, MSc, GlobalData’s Analyst covering Medical Devices, explains: “The top surgeries in the bariatric industry are the sleeve gastrectomy and the gastric bypass procedure, both of which are performed with bariatric stapling devices. The number of these procedures performed annually is expected to increase and will contribute to an overall growth in the bariatric stapling segment and in the bariatric surgery devices market as a whole.”

Within the other two bariatric surgery devices segments, there are divergent trends. While the gastric band market segment is expected to see a decrease in sales, gastric balloons are new devices that are expected to see continuous growth over the forecast period.

Babin continues: “The gastric band segment is projected to experience a significant decline in total procedures performed and therefore in total market value. This is due to recent long-term studies discovering a high number of long-term complications following gastric banding procedures.

“By contrast, the new gastric balloon procedure is increasing in popularity, aided by a drive for less-invasive procedures. It is a non-surgical, short-term treatment option, implanted directly into the stomach through the mouth.”

There are two major players in the bariatric surgery devices market, Medtronic and Ethicon Endo-surgery, which combined account for over 85% of the total bariatric surgery devices market. GlobalData expecte these companies to remain market leaders throughout the forecast period, particularly as they both already have devices in the bariatric stapling segment, the largest segment in this industry.

Babin concludes: “There are several smaller players in the industry, accounting for the remaining market share. For example, Apollo Endosurgery, Cousin Biotech, and ReShape are important players in both the gastric banding and gastric balloon market segments.”

Related Intelligence

Want more Insight like this?

Our interactive subscription platform has the most comprehensive data and analysis in your industry.

Request a Demo

Related Consulting

How can we help your business?

Our consultants are skilled in every specialist market niche to deliver solutions specifically designed for your individual requirements.

Request a Callback

Media Enquiries

If you are a member of the press or media and require any further information, please get in touch, as we’re very happy to help.

Emailpr@globaldata.com
PhoneEMEA: +44 207 832 4399
PhoneAPAC: +91 40 6616 6809
Onlinecontact online

56% of #consumers are concerned about the impact of diet. Join us for more insight @incosmetics #cosmetics #trends… https://t.co/wJOJOqYIJF